Security key
36269B105
- Security type / class
- Equity / COM
- Total 13F shares
- 1,825,471
- Total 13F value
- $3,943,571
- Share change
- +484,890
- Put/Call ratio
- 186%
- SEC-reported price per share
- $2.16
- Number of holders
- 24
- Value change
- +$1,072,825
- Number of buys
- 18
- Number of sells
- 5
Open additional details 1 more signal available
Report period
Q4 2024
Institutions
24
Top holders
10
GANX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Gain Therapeutics, Inc. SEC filings
Gain Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 36269B105
Recent filing periods:
Ownership snapshot
Top reported holders of GANX - Gain Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Gotham Asset Management, LLC
Disclosed value leader
Gotham Asset Management, LLC
Comparable rows
0/15
Latest evidence
30 Sep 2024
13F
3/4/5
Highest disclosed value: $7,377,754
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Gotham Asset Management, LLC has the largest disclosed position value at $7.38M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Gotham Asset Management, LLC's linked filing trail.
Disclosed position value
Top 5
Gotham Asset Management, LLC
$7.38M
DME Capital Management, LP
$1.01M
GEODE CAPITAL MANAGEMENT, LLC
$484.2K
VANGUARD GROUP INC
$258.5K
BlackRock, Inc.
$151.2K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Gotham Asset Management, LLC |
13F
Company
|
—
class O/S missing
|
$7,377,754
334,592 shares
|
— | 30 Sep 2024 |
| DME Capital Management, LP |
13F
Company
|
—
class O/S missing
|
$1,007,711
566,130 shares
|
— | 30 Sep 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$484,157
271,972 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$258,487
145,217 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
—
class O/S missing
|
$151,165
84,924 shares
|
— | 30 Sep 2024 |
| Charles Evan Ballantyne |
3/4/5
Chief Financial Officer
|
—
mixed-class rows
|
$125,000
150,000 shares
mixed-class rows
|
— | 10 Apr 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
24
Shares
1,825,471
Rows available
24
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
18
Q4 2024 holders
24
Holder diff
6
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend